YDESW YD Bio Limited Warrants
$0.64▲ +39.70%
Healthcare
Other
Volume 1.1K
Avg Volume (10D) –
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
0.60 - 0.64
% vs 50 MA
39.85%
% vs 200 MA
–%
RSI-14
55.2
MACD Histogram
-0.0100
Beta (1Y vs SPY)
-0.76
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026
GlobeNewswire · Aug 31, 2026 6:00 PM ET
YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
GlobeNewswire · Aug 25, 2026 8:00 AM ET
YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
GlobeNewswire · Aug 11, 2026 8:00 AM ET
YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research
GlobeNewswire · Aug 4, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.